Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Operating Expenses (2009 - 2026)

Updated

Alnylam Pharmaceuticals' Operating Expenses was $1.06 billion in Q2 2026, up 34.1% from $789.89 million a year earlier and up 17.9% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Operating Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Alnylam Pharmaceuticals' Operating Expenses was $3.8 billion through Jun 30, 2026, up 44.0% year-over-year; for FY2025, it was $3.21 billion, up 32.5% from FY2024.

  • Operating Expenses has now increased for ten consecutive years, with a five-year compound annual growth rate of 19.4% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $2.43 billion in FY2024 (+14.9%), $2.11 billion in FY2023 (+15.8%), $1.82 billion in FY2022 (+17.4%) and $1.55 billion in FY2021 (+17.5%).
  • The Q2 2026 figure marks the highest quarterly Operating Expenses in data going back to Q2 2009.
  • Compared with a year earlier, Operating Expenses has increased for 17 straight quarters, with growth averaging 31.3% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q1 2026 (growth of 56.0%); the worst was Q1 2022 (a decline of 1.1%).
  • Per Business Quant data, ALNY's Operating Expenses in the three quarters before Q2 2026 was $898.54 million (Q1 2026), $965.32 million (Q4 2025) and $881.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 10.12 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 10.56 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -9.70 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 2.09 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 1.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.06 Bn
Mar 31, 2026 898.54 Mn
Dec 31, 2025 965.32 Mn
Sep 30, 2025 881.04 Mn
Jun 30, 2025 789.89 Mn
Mar 31, 2025 576.11 Mn
Dec 31, 2024 698.33 Mn
Sep 30, 2024 577.82 Mn
Jun 30, 2024 611.21 Mn
Mar 31, 2024 537.77 Mn
Dec 31, 2023 556.12 Mn
Sep 30, 2023 536.66 Mn
Jun 30, 2023 548.59 Mn
Mar 31, 2023 469.10 Mn
Dec 31, 2022 523.65 Mn
Sep 30, 2022 522.35 Mn
Jun 30, 2022 416.50 Mn
Mar 31, 2022 359.99 Mn
Dec 31, 2021 453.10 Mn
Sep 30, 2021 369.31 Mn
API Access

Alnylam Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ALNY&period=max&api_key=YOUR_API_KEY